Cancer and Heart Disease Treatments dominate Medicines Milestones report
Cancer and Heart Disease Treatments dominate Medicines Milestones report

The Medicines Milestones report has unveiled that 795 treatments had received green signal in a decade up to 2011. Cancer and cardiovascular treatments were found to be leading the list with 115 drug approvals for cancer drugs and 82 for heart diseases.

The approvals being given by the Therapeutic Goods Administration did not forget to make sure that vaccines also get timely approvals from them. This is the reason that vaccines stand third in the row, as 57 approvals were given for the prevention of different problems.

Some of the vaccines, which were approved, were for whooping cough, measles, mumps and rubella and for cervical cancer and influenza. Only one area where improvements are thought to be done is depression, as mere six treatments were being approved.

It is not that treatments for mental conditions were not being approved, but all the 60 treatments were quite different in nature. Some dealt with anxiety and others were in regard to addiction disorders.

However, overall it was found that things have improved a lot due to the availability of these drugs. "While many of the new medicines will help large numbers of people, there were also treatments for much rarer conditions", said Dr. Brendan Shaw, who has been associated with the Australian Medicines Industry.

Latest News

Mentally Disturbed Pregnant Woman wants Medical Abortion
Rise in Complaints and Complication for Social Workers by Cap on care Expenditur
GPs’ Chief inspector to be Appointed Soon
Babies Sharing Beds with Parents Under Threat of Cot deaths
High Intake of Saturated and Unsaturated Fat Can Increase Risk of AMD
Australian History Might be Re-Written as an Outcome of an Ancient Discovery
The Opportunity Rover of NASA Ruined the 40-Year-Old Record of Lengthiest Extrat
NASA Telescope Kepler Might Get Terminated Forever
Some Big News Coming
Dark-Skinned People also Vulnerable to Skin Cancer
Price Disclosure Delivers Almost 70% of $18 Billion of Savings by 2017-18